Pharma IP rights are critical, trade group says
MLex Summary: Strong intellectual property rights are vital to the development of new drugs, an industry trade group said. "In the research-based biopharmaceutical industry, IP rights are critical to fostering innovation, ensuring continued...To view the full article, register now.
Already a subscriber? Click here to view full article